CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other conditions. Operating a CLIA-certified laboratory in Phoenix, AZ, CND launched the Syn-One Test™ as the first commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid in the confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF). Through analysis of three small punch skin biopsies provided by a referring physician, CND offers a convenient, accurate, minimally invasive alternative to aid in the diagnosis of neurodegenerative diseases. The company has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field.
Location: United States, Arizona, Phoenix
Employees: 11-50
Total raised: $24.7M
Founded date: 2017
Funding Rounds 5
| Date | Series | Amount | Investors |
| 06.04.2023 | Seed | $12.5M | Top Corner... |
| 18.05.2022 | Grant | $2.4M | - |
| 03.02.2022 | Seed | $5M | - |
| 02.04.2021 | Seed | $2.4M | - |
| 27.10.2020 | Grant | $2.4M | - |
Mentions in press and media 6
| Date | Title | Description | Source |
| 06.04.2023 | CND Life Sciences Closes $4.5M Series Seed 3 Funding; $12.5M... | CND Life Sciences, a Scottsdale, AZ-based medical technology company, raised an additional $1m in ve... | finsmes.co... |
| 03.02.2022 | CND Life Sciences Raises $5.0M in Series Seed 2 Funding | CND Life Science, a Phoenix AZ-based medical diagnostics company, raised $5M in Series Seed 2 fundin... | finsmes.co... |
| 24.03.2021 | CND Life Sciences Closes $2.4M Seed Financing | CND Life Sciences, Inc., a Phoenix, AZ-based innovative medical technology company, closed a $2.4m s... | finsmes.co... |
| - | CND Life Sciences | “CND LIfe Sciences - Home of the Syn-One Test™” | fastfounde... |
| - | CND Life Sciences Raises $12.5 Million To Develop Skin-Based... | CND Life Sciences – a medical technology company pioneering the development of reliable skin-based t... | pulse2.com... |
| - | CND Life Sciences | “Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on dis... | fastfounde... |